CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women

Clinical Trial2020 Dec 11;S1936-878X(20)30941-4.

JOURNAL:JACC Cardiovasc Imaging. Article Link

High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonobstructive Coronary Disease: A Randomized Study

J Henzel, C Kępka, M Kruk et al. Keywords: high-risk plaque burden; ASCVD progression; lifestyle intervention; RCT

Full Text PDF